Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Eskelin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Acta Ophthalmologica|September 2, 2008
Photodynamic therapy with verteporfin to induce regression of aggressive retinal astrocytomasSebastian Eskelin, Petri Tommila, Tapani Palosaari, et al.
Acta Ophthalmologica|October 22, 2008
Mortality after uveal and conjunctival melanoma: which tumour is more deadly?Emma Kujala, Seppo Tuomaala, Sebastian Eskelin, et al.
Retina (Philadelphia, Pa.)|July 1, 2014
Management of choroidal melanomas less than 10 mm in largest basal diameter with a 10-mm ruthenium plaqueSusanna Salkola, Jorma Heikkonen, Sebastian Eskelin, et al.
Investigative Ophthalmology & Visual Science|October 31, 2002
Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whitesSeppo Tuomaala, Sebastian Eskelin, Ahti Tarkkanen, et al.
Cancer|January 9, 2003
A prognostic model and staging for metastatic uveal melanomaSebastian Eskelin, Seppo Pyrhönen, Marjo Hahka-Kemppinen, et al.
The British Journal of Ophthalmology|October 20, 2021
Presumed incipient choroidal melanoma: proposed diagnostic criteria and managementSusanna Jouhi, Ranaa T Al-Jamal, Martin Täll, et al.
Cancer|November 19, 2002
Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanomaSeppo Pyrhönen, Marjo Hahka-Kemppinen, Timo Muhonen, et al.
American Journal of Ophthalmology|June 15, 2016
Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology GroupTero T Kivelä, Sophie Piperno-Neumann, Laurence Desjardins, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Acta Ophthalmologica|September 2, 2008
Photodynamic therapy with verteporfin to induce regression of aggressive retinal astrocytomasSebastian Eskelin, Petri Tommila, Tapani Palosaari, et al.
Acta Ophthalmologica|October 22, 2008
Mortality after uveal and conjunctival melanoma: which tumour is more deadly?Emma Kujala, Seppo Tuomaala, Sebastian Eskelin, et al.
Retina (Philadelphia, Pa.)|July 1, 2014
Management of choroidal melanomas less than 10 mm in largest basal diameter with a 10-mm ruthenium plaqueSusanna Salkola, Jorma Heikkonen, Sebastian Eskelin, et al.
Investigative Ophthalmology & Visual Science|October 31, 2002
Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whitesSeppo Tuomaala, Sebastian Eskelin, Ahti Tarkkanen, et al.
Cancer|January 9, 2003
A prognostic model and staging for metastatic uveal melanomaSebastian Eskelin, Seppo Pyrhönen, Marjo Hahka-Kemppinen, et al.
The British Journal of Ophthalmology|October 20, 2021
Presumed incipient choroidal melanoma: proposed diagnostic criteria and managementSusanna Jouhi, Ranaa T Al-Jamal, Martin Täll, et al.
Cancer|November 19, 2002
Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanomaSeppo Pyrhönen, Marjo Hahka-Kemppinen, Timo Muhonen, et al.
American Journal of Ophthalmology|June 15, 2016
Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology GroupTero T Kivelä, Sophie Piperno-Neumann, Laurence Desjardins, et al.
Pageof 1